BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32750721)

  • 1. Reappraising the Diagnostic Accuracy of Post-Treatment Whole-Body Scans for Differentiated Thyroid Carcinoma.
    Nava CF; Scheffel RS; Zanella AB; Zelmanovitz F; Maia AL; Dora JM
    Horm Metab Res; 2020 Dec; 52(12):834-840. PubMed ID: 32750721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
    Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
    Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e457-65. PubMed ID: 31665318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
    Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
    Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Less than 2% of the Low- and Intermediate-Risk Differentiated Thyroid Cancers Show Distant Metastases at Post-Ablation Whole-Body Scan.
    Agate L; Bianchi F; Brozzi F; Santini P; Molinaro E; Bottici V; Viola D; Lorusso L; Vitti P; Elisei R
    Eur Thyroid J; 2019 Apr; 8(2):90-95. PubMed ID: 31192148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer.
    Iwano S; Ito S; Kamiya S; Ito R; Kato K; Naganawa S
    Nagoya J Med Sci; 2020 May; 82(2):205-215. PubMed ID: 32581401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation Criteria in Solid Tumors or Doubling Time?
    Song E; Ahn J; Jeon MJ; Lee SM; Lee JH; Kim TY; Baek JH; Kim WB; Shong YK; Kim WG
    Thyroid; 2020 Mar; 30(3):418-424. PubMed ID: 31880976
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients: Is Thyroglobulin Stimulation Required?
    Moreno I; Hirsch D; Duskin-Bitan H; Dicker-Cohen T; Shimon I; Robenshtok E
    Thyroid; 2020 Jun; 30(6):863-870. PubMed ID: 31928205
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.
    Samanci C; Onal Y; Sager S; Asa S; Ustabasioglu FE; Alis D; Akman C; Sonmezoglu K
    Curr Med Imaging Rev; 2019; 15(10):956-964. PubMed ID: 32008523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid lobectomy for low-risk thyroid cancers.
    Puttergill B; Khan S; Christakis I; Dumbill R; Mclaren A; Sadler G; Mihai R
    Ann R Coll Surg Engl; 2022 Feb; 104(2):113-116. PubMed ID: 35100851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
    Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
    Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of follicular thyroid carcinoma in children and adolescents: A study of 30 cases.
    Spinelli C; Rallo L; Morganti R; Mazzotti V; Inserra A; Cecchetto G; Massimino M; Collini P; Strambi S
    J Pediatr Surg; 2019 Mar; 54(3):521-526. PubMed ID: 29935896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications.
    Morbelli S; Ferrarazzo G; Pomposelli E; Pupo F; Pesce G; Calamia I; Fiz F; Clapasson A; Bauckneht M; Minuto M; Sambuceti G; Giusti M; Bagnasco M
    J Endocrinol Invest; 2017 Apr; 40(4):417-424. PubMed ID: 27844413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.